Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment

Head and Neck

Volumn 36, Issue 10, 2014, Pages 1392-1397

  Starmer, Heather M ^a   Tippett, Donna ^a   Webster, Kimberly ^a   Quon, Harry ^a   Jones, Bronwyn ^a   Hardy, Sarah ^a   Gourin, Christine G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Chemoradiation; Dysphagia; Head and neck cancer; Oropharyngeal cancer; Swallowing

Indexed keywords

CETUXIMAB; CISPLATIN; DASATINIB; DOCETAXEL; FLUOROURACIL; PACLITAXEL DERIVATIVE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FLUOROSCOPY; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NECK DISSECTION; ORGAN PRESERVATION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PENETRATION ASPIRATION SCALE; SQUAMOUS CELL CARCINOMA; SWALLOWING; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; FLUOROSCOPY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS;

EID: 84908067787     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23465     Document Type: Conference Paper

References (22)

1. Kotz T, Costello R, Li Y, Posner MR. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 2004;26:365-372.
2. Graner DE, Foote RL, Kasperbauer JL, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 2003;113: 573-579.
3. Lazarus C. Tongue strength and exercise in healthy individuals and head and neck cancer patients. Semin Speech Lang 2006;27:260-267.
4. Gillespie M, Brodsky MB, Day TA, Sharma AK, Lee F, Martin-Harris B. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otorhinolaryngol Head Neck Surg 2005;131:615-619.
5. Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011;81:e93-e99.
6. Roe JW, Carding PN, Dwivedi RC, et al. Swallowing outcomes following intensity modulated radiation therapy (IMRT) for head & neck cancer - a systematic review. Oral Oncol 2010;46:727-733.
7. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:1356-1365.
8. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007;68:1289-1298.
9. Ricchetti F, Wu B, McNutt T, et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011;80:161-168.
10. Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 2008;118:39-43.
11. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CR, Hilgers FJ. A randomized preventative rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 2011;26:155-170.
12. Kotz T, Federman AD, Kao J, et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg 2012;138:376-382.
13. Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R. "Pharyngocise": randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Bio Phys 2012;83:210-219.
14. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 1996;11:93-98.
15. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 2005;86:1516-1520.
16. Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 2012;138:123-133.
17. Posner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from and international phase III trial. Ann Oncol 2011;22:1071-1077.
18. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
19. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-269.
20. Sharma A, Méndez E, Yueh B, et al. Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 2012;146:739-745.
21. Starmer H, Gourin C, Lua LL, Burkhead L. Pretreatment swallowing assessment in head and neck cancer patients. Laryngoscope 2011;121:1208-1211.
22. Stoeckli SJ, Huisman TA, Seifert B, Martin-Harris BJ. Interrater reliability of videofluoroscopic swallow evaluation. Dysphagia 2003;18:53-57.